These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32831241)

  • 1. A new high-pressure benzocaine polymorph - towards understanding the molecular aggregation in crystals of an important active pharmaceutical ingredient (API).
    Patyk-Kaźmierczak E; Kaźmierczak M
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2020 Feb; 76(Pt 1):56-64. PubMed ID: 32831241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the polymorphism of benzocaine; a low-temperature structural phase transition for form (II).
    Chan EJ; Rae AD; Welberry TR
    Acta Crystallogr B; 2009 Aug; 65(Pt 4):509-15. PubMed ID: 19617687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight to the thermodynamic stability of molecular crystals through crystallographic studies of a multipolymorph system.
    Ng AT; Lai C; Dabros M; Gao Q
    J Pharm Sci; 2014 Nov; 103(11):3423-3431. PubMed ID: 25252084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density preference of the ambient and high-pressure polymorphs of DL-menthol.
    Roszak K; Katrusiak A
    IUCrJ; 2023 May; 10(Pt 3):341-351. PubMed ID: 37079398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzocaine polymorphism: pressure-temperature phase diagram involving forms II and III.
    Gana I; Barrio M; Do B; Tamarit JL; Céolin R; Rietveld IB
    Int J Pharm; 2013 Nov; 456(2):480-8. PubMed ID: 23994015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-crystal diffuse scattering studies on polymorphs of molecular crystals. I. The room-temperature polymorphs of the drug benzocaine.
    Chan EJ; Welberry TR; Goossens DJ; Heerdegen AP; Beasley AG; Chupas PJ
    Acta Crystallogr B; 2009 Jun; 65(Pt 3):382-92. PubMed ID: 19461149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-pressure polymorph of chlorpropamide formed on hydrostatic compression of the α-form in saturated ethanol solution.
    Seryotkin YV; Drebushchak TN; Boldyreva EV
    Acta Crystallogr B; 2013 Feb; 69(Pt 1):77-85. PubMed ID: 23364463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of crystallization behavior in drug/polyethylene glycol solid dispersions.
    Zhu Q; Harris MT; Taylor LS
    Mol Pharm; 2012 Mar; 9(3):546-53. PubMed ID: 22299821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The discovery and investigation of a crystalline solid solution of an active pharmaceutical ingredient.
    Patel MA; AbouGhaly MHH; Chadwick K
    Int J Pharm; 2017 Oct; 532(1):166-176. PubMed ID: 28847668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism and crystallization of active pharmaceutical ingredients (APIs).
    Lu J; Rohani S
    Curr Med Chem; 2009; 16(7):884-905. PubMed ID: 19275600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the pH-dependent binding of benzocaine and lysozyme by fluorescence and absorbance.
    Li S; Li D
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Nov; 82(1):396-405. PubMed ID: 21820949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a targeted polymorph screening approach for a complex polymorphic and highly solvating API.
    Campeta AM; Chekal BP; Abramov YA; Meenan PA; Henson MJ; Shi B; Singer RA; Horspool KR
    J Pharm Sci; 2010 Sep; 99(9):3874-86. PubMed ID: 20575000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural characteristics and crystal polymorphism of three local anaesthetic bases crystal polymorphism of local anaesthetic drugs: part VII.
    Schmidt AC
    Int J Pharm; 2005 Jul; 298(1):186-97. PubMed ID: 15955643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of polymorph conversion of an active pharmaceutical ingredient in wet granulation using NIR calibration models generated from the premix blends.
    Li W; Worosila GD; Wang W; Mascaro T
    J Pharm Sci; 2005 Dec; 94(12):2800-6. PubMed ID: 16258990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new polymorph and two pseudopolymorphs of pyrimethamine.
    Tutughamiarso M; Bolte M
    Acta Crystallogr C; 2011 Nov; 67(Pt 11):o428-34. PubMed ID: 22051957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress of structural study of polymorphic pharmaceutical drugs.
    Higashi K; Ueda K; Moribe K
    Adv Drug Deliv Rev; 2017 Aug; 117():71-85. PubMed ID: 27940141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in 3-acetyl-4-hydroxy-2H-chromen-2-one.
    Ghouili A; Brahmia A; Ben Hassen R
    Acta Crystallogr C Struct Chem; 2015 Oct; 71(Pt 10):873-7. PubMed ID: 26422214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Pressure Polymorphs Nucleated and Stabilized by Rational Doping under Ambient Conditions.
    Safari F; Katrusiak A
    J Phys Chem C Nanomater Interfaces; 2021 Oct; 125(42):23501-23509. PubMed ID: 34737842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pressure on the crystal structure of salicylaldoxime-I, and the structure of salicylaldoxime-II at 5.93 GPa.
    Wood PA; Forgan RS; Henderson D; Parsons S; Pidcock E; Tasker PA; Warren JE
    Acta Crystallogr B; 2006 Dec; 62(Pt 6):1099-111. PubMed ID: 17108665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.